Connect with us

5 Biotech Small-Cap Stocks On Robinhood and Webull To Watch on Monday

5 Biotech Penny Stocks On Robinhood and Webull To Watch on Monday

Published

on

This article was originally published by PennyStocks.

Penny Stocks To Watch For March 2021 If You Like The Biotech Sector

As we approach the third week of March, penny stocks seem to be on a hot streak. This is a combination of the massive decline in covid cases and the $1.9 trillion stimulus package passing. Also, investors’ fear about potential long-term inflation in the U.S. seems to be dwindling.

All of this adds up to show that investors are quite bullish about the near term. And this bullishness is extending from blue-chip stocks to penny stocks. While not all cheaper stocks are winners, a few industries are seeing more attention than others. This includes biotech, mining, technology, and others. 

It makes sense that these industries would be gaining momentum given the current events. And as the economy continues to return to normalcy, the hopes are that more industries will see their values rise. Investors should remember that this process takes time. And research will always be your best friend. So when making a list of penny stocks to watch, it’s critical to consider what is going on in the world.

Are Biotech Penny Stocks On Your Watch List In March?

This has lead many to biotech. Look at benchmark ETFs like the Nasdaq Biotechnology Index ETF (NASDAQ: IBB) or the S&P Biotech ETF (NYSE: XBI). Both had gone into bear market territory following the late-February pullback. The XBI dipped 26.5% from its high, and the IBB dropped 18%. But since then, both have experienced an aggressive rebound worth noting. In fact, since reaching their lows, these biotech ETFs bounced back between 9% and 14%. This same period saw the SPY and QQQ only rebound 6-7%.

Retail or “Robinhood traders” continue seeking out volatility, and biotech has certainly become a source of that. Even with the rally, the sector has seen that both XBI and IBB are still off their record levels. What’s more, if you look at the 100 most popular stocks on Robinhood right now, it’s peppered with a slew of different biotech names.

Since biotech stocks have far outpaced broader markets, this could warrant a closer look. All things in consideration, here are five penny stocks to watch heading into the second half of March. 

Biotech Penny Stocks On Robinhood to Watch Right Now 

  1. GT Biopharma Inc. (NASDAQ: GTBP)
  2. Acer Therapeutics Inc. (NASDAQ: ACER
  3. Biolase Inc. (NASDAQ: BIOL
  4. Synthetic Biologics Inc. (NYSE: SYN
  5. IsoRay Inc. (NYSE: ISR

Penny Stocks To Watch #1: GT Biopharma Inc.

Shares of GT Biopharma have flirted with the upper end of the penny stock range for the last few weeks, with the last few days seeing a big boost in market momentum. Last Tuesday, GTBP stock experienced the most active trading day in its recent history, with more than 4.4 million shares traded. What was the source of excitement?

The company announced preclinical results for its ROR1 TriKE product candidate as a prospective therapy for prostate cancer treatment. GT Biopharma explained that ROR1 recently showed to be overexpressed on certain cancer cells and appears to play a functional role in “promoting migration/invasion and influencing the metastatic potential” of various solid tumor cancers. By targeting ROR1 on cancer cells with its TriKE platform and redirecting NK cells to attack and kill cancer cells expressing ROR1, GT Biopharma said it could result in a treatment that limits the metastatic potential and invasiveness of certain solid tumor cancers.

However, something to note with GT Biopharma is that this is just one piece of the company’s broader treatment pipeline. The TriKE platform has become the framework for numerous therapeutics, including GT’s GTB3550. It’s initially indicated for treating acute myeloid leukemia, myelodysplastic syndrome. Interim data has already been released, showing progress in its current Phase I/II clinical trials. Not only were no toxicities observed, but significant benefits were observed after treatment with GTB-3550 in the seven patients that have been enrolled & have also completed therapy. An 8th patient has also begun treatment in this trial.

Heading into this week, GT Biopharma will also present at the Roth Conference on Wednesday. So if GTBP stock is on your list, that date may be something to keep in mind.

biotech penny stocks on robinhood to watch GT Biopharma Inc. GTBP stock chart

#2: Acer Therapeutics Inc. 

An interesting biotech penny stock right now is Acer Therapeutics Inc. The company acquires and develops therapies that treat rare illnesses. This includes those that are otherwise unmet by current treatments. In its latest Q4 report published a few weeks ago, the company announced some exciting updates.

Also See: 4 Biotech Penny Stocks To Watch Before Next Week

CEO Chris Schelling stated that “in spite of the challenges presented by the global pandemic in 2020, we continued to advance our existing programs while expanding our pipeline. As a result, we anticipate a number of key milestones next quarter, including the proposed ACER-001 pre-NDA meeting with the FDA, continuing to work toward a potential ACER-001 collaboration and license agreement with Relief Therapeutics.”

Financially, Acer ended the quarter with more than $5.8 million in cash and cash equivalents. While it did pull in a net loss of $6.2 million, this is quite common amongst biotech companies. Before commercializing a compound, biotech companies will often incur losses. This is due to the massive capital expenditures involved in producing a new drug.

In addition to this, the company recently submitted a Type B meeting request to the FDA for its Edviso (celiprolol) compound. The company is also developing ACER-2820, which could be an efficacious treatment option for Covid-19 patients. All of this adds up to show that Acer has a lot in its pipeline right now. While it may take time before it reaches more milestones, ACER could be worth watching.

biotech penny stocks on robinhood to watch Acer Therapeutics Inc. ACER stock chart

#3: Biolase Inc. 

Biolase Inc. is a penny stock that we have frequently discussed over the past few months. In that time, it has made some big strides with its business model. Biolase is a producer of dental lasers that are used in a large range of procedures. With over 271 patented and 40 patent-pending technologies, Biolase is constantly innovating with its products. The patents it holds for its lasers allow it to claim some of the most advanced dental laser system options on the market.

When 2020 turned the corner, Biolase reported hitting a milestone of selling more than 41,200 laser systems across 80 countries. Shares have climbed several times in the past few months off of news regarding its laser systems. A week ago, the European Patent Office announced that it might give a new specification to Biolase’ Dual Pulse-Width Medical Laser With Presets. If Biolase receives this, it would be another large win for the company.

A few weeks prior, the company announced the closing of a sizable $14.4 million bought deal offering. CEO Todd Norbe stated that “this latest offering has bolstered our cash to over $40 million and provides us with the necessary resources to execute the Biolase growth strategy.”

Because dental procedures have resumed to most of their pre-covid levels, many investors are bullish on the future of Biolase. While it is affected by the pandemic, the company is working to build new strategies. This goes hand in hand with its need to continue innovating and receiving new patents. With all of this in mind, is BIOL a penny stock to watch?

biotech penny stocks on robinhood to watch Biolase Inc. BIOL stock chart

#4: Synthetic Biologics Inc. 

After Maxim Group upgraded SYN from a hold to a buy, shares of the biotech company dramatically increased. In addition to this, Maxim Group analysts gave a price target for SYN of $2.50. This represents a 10% or so gain from where it was before the rating. At the end of Friday, March 12th, SYN stock had shot up by over 29% to $0.92.

[Read More] Best Penny Stocks To Buy Right Now? 4 For Next Week’s Watch List

This rating comes only a few days after the company released its year-end financial and operational results. In the results, Synthetic Biologics posted over $72 million in cash on hand. It also stated that it should have enough cash to fund all clinical programs up to 2023. Also, it announced that it had received Institutional Review Board or IRB approval from Washington University School of Medicine in St. Louis for its SYN-004 compound. 

CEO Steven Shallcross stated that “we are more encouraged than ever by this outlook for the business as we have made important progress during the fourth quarter advancing and demonstrating the significant value of our clinical development programs. With a number of upcoming catalysts later this year, we believe there is potential to continue to deliver significant value for our shareholders.”

Shallcross went on to state that “during the fourth quarter of 2020, we also made significant progress and gained additional clarity on potential clinical development pathways for our SYN-020 IAP program.”

So with all these exciting programs in mind, SYN could be a penny stock to watch. 

biotech penny stocks on robinhood to watch Synthetic Biologics Inc. SYN stock chart

#5: IsoRay Inc. 

Back in February, IsoRay announced its Q2 results for 2021. With no major changes to its bottom line, ISR stock remained quite stable after the announcement. In the report, IsoRay managed to increase revenue by 7% year over year. Also, its revenue from non-prostate brachytherapy increased by more than 92% year over year.

While fewer surgeries occurred last year due to covid, IsoRay has managed to work around this, building its brachytherapy use cases along the way. CEO Lori Woods stated that “we are very pleased that we have been able to continue to make progress this quarter despite the ongoing challenges that the Covid-19 pandemic has presented. Amongst the highlights has been our continued success in expanding adoption of Celsium-131 in our core prostate market.” 

The company’s Cesium Blu brachytherapy seeds are used in broadening the indications that brachytherapy has overall. A few weeks ago, the company appointed Lisa Lauer to be its new VP of Business Development. With over 27 years of experience in the industry, Lauer’s addition could help develop IsoRay’s business model moving forward.

The company will also be presenting at the upcoming Oppenheimer 31st Annual Healthcare Conference on March 17th. This is important for investors as it could give insight into where the company is headed in the coming months. Since January, shares of the biotech penny stock are up by over 180%. With this bullish interest in mind, ISR could be one of the penny stocks to watch before next month.

biotech penny stocks on robinhood to watch IsoRay Inc. ISR stock chart

Click Here For Full Disclaimer

The post 5 Biotech Penny Stocks On Robinhood To Watch In March 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Read More

Continue Reading

Government

Survey Shows Declining Concerns Among Americans About COVID-19

Survey Shows Declining Concerns Among Americans About COVID-19

A new survey reveals that only 20% of Americans view covid-19 as "a major threat"…

Published

on

Survey Shows Declining Concerns Among Americans About COVID-19

A new survey reveals that only 20% of Americans view covid-19 as "a major threat" to the health of the US population - a sharp decline from a high of 67% in July 2020.

(SARMDY/Shutterstock)

What's more, the Pew Research Center survey conducted from Feb. 7 to Feb. 11 showed that just 10% of Americans are concerned that they will  catch the disease and require hospitalization.

"This data represents a low ebb of public concern about the virus that reached its height in the summer and fall of 2020, when as many as two-thirds of Americans viewed COVID-19 as a major threat to public health," reads the report, which was published March 7.

According to the survey, half of the participants understand the significance of researchers and healthcare providers in understanding and treating long COVID - however 27% of participants consider this issue less important, while 22% of Americans are unaware of long COVID.

What's more, while Democrats were far more worried than Republicans in the past, that gap has narrowed significantly.

"In the pandemic’s first year, Democrats were routinely about 40 points more likely than Republicans to view the coronavirus as a major threat to the health of the U.S. population. This gap has waned as overall levels of concern have fallen," reads the report.

More via the Epoch Times;

The survey found that three in ten Democrats under 50 have received an updated COVID-19 vaccine, compared with 66 percent of Democrats ages 65 and older.

Moreover, 66 percent of Democrats ages 65 and older have received the updated COVID-19 vaccine, while only 24 percent of Republicans ages 65 and older have done so.

“This 42-point partisan gap is much wider now than at other points since the start of the outbreak. For instance, in August 2021, 93 percent of older Democrats and 78 percent of older Republicans said they had received all the shots needed to be fully vaccinated (a 15-point gap),” it noted.

COVID-19 No Longer an Emergency

The U.S. Centers for Disease Control and Prevention (CDC) recently issued its updated recommendations for the virus, which no longer require people to stay home for five days after testing positive for COVID-19.

The updated guidance recommends that people who contracted a respiratory virus stay home, and they can resume normal activities when their symptoms improve overall and their fever subsides for 24 hours without medication.

“We still must use the commonsense solutions we know work to protect ourselves and others from serious illness from respiratory viruses, this includes vaccination, treatment, and staying home when we get sick,” CDC director Dr. Mandy Cohen said in a statement.

The CDC said that while the virus remains a threat, it is now less likely to cause severe illness because of widespread immunity and improved tools to prevent and treat the disease.

Importantly, states and countries that have already adjusted recommended isolation times have not seen increased hospitalizations or deaths related to COVID-19,” it stated.

The federal government suspended its free at-home COVID-19 test program on March 8, according to a website set up by the government, following a decrease in COVID-19-related hospitalizations.

According to the CDC, hospitalization rates for COVID-19 and influenza diseases remain “elevated” but are decreasing in some parts of the United States.

Tyler Durden Sun, 03/10/2024 - 22:45

Read More

Continue Reading

Government

Rand Paul Teases Senate GOP Leader Run – Musk Says “I Would Support”

Rand Paul Teases Senate GOP Leader Run – Musk Says "I Would Support"

Republican Kentucky Senator Rand Paul on Friday hinted that he may jump…

Published

on

Rand Paul Teases Senate GOP Leader Run - Musk Says "I Would Support"

Republican Kentucky Senator Rand Paul on Friday hinted that he may jump into the race to become the next Senate GOP leader, and Elon Musk was quick to support the idea. Republicans must find a successor for periodically malfunctioning Mitch McConnell, who recently announced he'll step down in November, though intending to keep his Senate seat until his term ends in January 2027, when he'd be within weeks of turning 86. 

So far, the announced field consists of two quintessential establishment types: John Cornyn of Texas and John Thune of South Dakota. While John Barrasso's name had been thrown around as one of "The Three Johns" considered top contenders, the Wyoming senator on Tuesday said he'll instead seek the number two slot as party whip. 

Paul used X to tease his potential bid for the position which -- if the GOP takes back the upper chamber in November -- could graduate from Minority Leader to Majority Leader. He started by telling his 5.1 million followers he'd had lots of people asking him about his interest in running...

...then followed up with a poll in which he predictably annihilated Cornyn and Thune, taking a 96% share as of Friday night, with the other two below 2% each. 

Elon Musk was quick to back the idea of Paul as GOP leader, while daring Cornyn and Thune to follow Paul's lead by throwing their names out for consideration by the Twitter-verse X-verse. 

Paul has been a stalwart opponent of security-state mass surveillance, foreign interventionism -- to include shoveling billions of dollars into the proxy war in Ukraine -- and out-of-control spending in general. He demonstrated the latter passion on the Senate floor this week as he ridiculed the latest kick-the-can spending package:   

In February, Paul used Senate rules to force his colleagues into a grueling Super Bowl weekend of votes, as he worked to derail a $95 billion foreign aid bill. "I think we should stay here as long as it takes,” said Paul. “If it takes a week or a month, I’ll force them to stay here to discuss why they think the border of Ukraine is more important than the US border.”

Don't expect a Majority Leader Paul to ditch the filibuster -- he's been a hardy user of the legislative delay tactic. In 2013, he spoke for 13 hours to fight the nomination of John Brennan as CIA director. In 2015, he orated for 10-and-a-half-hours to oppose extension of the Patriot Act

Rand Paul amid his 10 1/2 hour filibuster in 2015

Among the general public, Paul is probably best known as Capitol Hill's chief tormentor of Dr. Anthony Fauci, who was director of the National Institute of Allergy and Infectious Disease during the Covid-19 pandemic. Paul says the evidence indicates the virus emerged from China's Wuhan Institute of Virology. He's accused Fauci and other members of the US government public health apparatus of evading questions about their funding of the Chinese lab's "gain of function" research, which takes natural viruses and morphs them into something more dangerous. Paul has pointedly said that Fauci committed perjury in congressional hearings and that he belongs in jail "without question."   

Musk is neither the only nor the first noteworthy figure to back Paul for party leader. Just hours after McConnell announced his upcoming step-down from leadership, independent 2024 presidential candidate Robert F. Kennedy, Jr voiced his support: 

In a testament to the extent to which the establishment recoils at the libertarian-minded Paul, mainstream media outlets -- which have been quick to report on other developments in the majority leader race -- pretended not to notice that Paul had signaled his interest in the job. More than 24 hours after Paul's test-the-waters tweet-fest began, not a single major outlet had brought it to the attention of their audience. 

That may be his strongest endorsement yet. 

Tyler Durden Sun, 03/10/2024 - 20:25

Read More

Continue Reading

Government

The Great Replacement Loophole: Illegal Immigrants Score 5-Year Work Benefit While “Waiting” For Deporation, Asylum

The Great Replacement Loophole: Illegal Immigrants Score 5-Year Work Benefit While "Waiting" For Deporation, Asylum

Over the past several…

Published

on

The Great Replacement Loophole: Illegal Immigrants Score 5-Year Work Benefit While "Waiting" For Deporation, Asylum

Over the past several months we've pointed out that there has  been zero job creation for native-born workers since the summer of 2018...

... and that since Joe Biden was sworn into office, most of the post-pandemic job gains the administration continuously brags about have gone foreign-born (read immigrants, mostly illegal ones) workers.

And while the left might find this data almost as verboten as FBI crime statistics - as it directly supports the so-called "great replacement theory" we're not supposed to discuss - it also coincides with record numbers of illegal crossings into the United States under Biden.

In short, the Biden administration opened the floodgates, 10 million illegal immigrants poured into the country, and most of the post-pandemic "jobs recovery" went to foreign-born workers, of which illegal immigrants represent the largest chunk.

Asylum seekers from Venezuela await work permits on June 28, 2023 (via the Chicago Tribune)

'But Tyler, illegal immigrants can't possibly work in the United States whilst awaiting their asylum hearings,' one might hear from the peanut gallery. On the contrary: ever since Biden reversed a key aspect of Trump's labor policies, all illegal immigrants - even those awaiting deportation proceedings - have been given carte blanche to work while awaiting said proceedings for up to five years...

... something which even Elon Musk was shocked to learn.

Which leads us to another question: recall that the primary concern for the Biden admin for much of 2022 and 2023 was soaring prices, i.e., relentless inflation in general, and rising wages in particular, which in turn prompted even Goldman to admit two years ago that the diabolical wage-price spiral had been unleashed in the US (diabolical, because nothing absent a major economic shock, read recession or depression, can short-circuit it once it is in place).

Well, there is one other thing that can break the wage-price spiral loop: a flood of ultra-cheap illegal immigrant workers. But don't take our word for it: here is Fed Chair Jerome Powell himself during his February 60 Minutes interview:

PELLEY: Why was immigration important?

POWELL: Because, you know, immigrants come in, and they tend to work at a rate that is at or above that for non-immigrants. Immigrants who come to the country tend to be in the workforce at a slightly higher level than native Americans do. But that's largely because of the age difference. They tend to skew younger.

PELLEY: Why is immigration so important to the economy?

POWELL: Well, first of all, immigration policy is not the Fed's job. The immigration policy of the United States is really important and really much under discussion right now, and that's none of our business. We don't set immigration policy. We don't comment on it.

I will say, over time, though, the U.S. economy has benefited from immigration. And, frankly, just in the last, year a big part of the story of the labor market coming back into better balance is immigration returning to levels that were more typical of the pre-pandemic era.

PELLEY: The country needed the workers.

POWELL: It did. And so, that's what's been happening.

Translation: Immigrants work hard, and Americans are lazy. But much more importantly, since illegal immigrants will work for any pay, and since Biden's Department of Homeland Security, via its Citizenship and Immigration Services Agency, has made it so illegal immigrants can work in the US perfectly legally for up to 5 years (if not more), one can argue that the flood of illegals through the southern border has been the primary reason why inflation - or rather mostly wage inflation, that all too critical component of the wage-price spiral  - has moderated in in the past year, when the US labor market suddenly found itself flooded with millions of perfectly eligible workers, who just also happen to be illegal immigrants and thus have zero wage bargaining options.

None of this is to suggest that the relentless flood of immigrants into the US is not also driven by voting and census concerns - something Elon Musk has been pounding the table on in recent weeks, and has gone so far to call it "the biggest corruption of American democracy in the 21st century", but in retrospect, one can also argue that the only modest success the Biden admin has had in the past year - namely bringing inflation down from a torrid 9% annual rate to "only" 3% - has also been due to the millions of illegals he's imported into the country.

We would be remiss if we didn't also note that this so often carries catastrophic short-term consequences for the social fabric of the country (the Laken Riley fiasco being only the latest example), not to mention the far more dire long-term consequences for the future of the US - chief among them the trillions of dollars in debt the US will need to incur to pay for all those new illegal immigrants Democrat voters and low-paid workers. This is on top of the labor revolution that will kick in once AI leads to mass layoffs among high-paying, white-collar jobs, after which all those newly laid off native-born workers hoping to trade down to lower paying (if available) jobs will discover that hardened criminals from Honduras or Guatemala have already taken them, all thanks to Joe Biden.

Tyler Durden Sun, 03/10/2024 - 19:15

Read More

Continue Reading

Trending